» Articles » PMID: 6997892

The Pathopharmacology of Malignant Hyperpyrexia

Overview
Journal Pharmacol Ther
Specialty Pharmacology
Date 1980 Jan 1
PMID 6997892
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.

Steinfath M, Singh S, Scholz J, Becker K, Lenzen C, Wappler F J Mol Med (Berl). 1995; 73(1):35-40.

PMID: 7633940 DOI: 10.1007/BF00203617.


Malignant hyperthermia: molecular defects in membrane permeability.

Cheah K, Cheah A Experientia. 1985; 41(5):656-61.

PMID: 3888661 DOI: 10.1007/BF02007707.


Propofol for anesthesia in a patient susceptible to malignant hyperthermia.

Rosenberg M Anesth Prog. 1991; 38(3):96-8.

PMID: 1839946 PMC: 2161979.


Dantrolene inhibits halothane-induced membrane reorganization. A study using 31P-NMR and differential scanning calorimetry.

Gaillard S, Dufourc E, Bonnet M, Renou J Eur Biophys J. 1992; 21(1):13-9.

PMID: 1516557 DOI: 10.1007/BF00195439.